A non-promotional initiative organised and sponsored by Bristol-Myers Squibb Pharmaceuticals Limited

This website contains information and resources intended only for Healthcare Professionals based in the UK and Ireland only.

Modernising Bladder Cancer - an update

Wednesday 28th April 2021, 17.00 - 18.45

Speakers

Mr Amar Mohee

Manchester University NHS Foundation Trust

Amar Mohee is a consultant urological surgeon, working at the Manchester University NHS Foundation Trust (MFT). Amar did his medical training at the University of Manchester, before moving across the Pennines to undertake research in urology at the University of Leeds. He was awarded a doctorate in medicine for his thesis titled ‘Infection in urological practice: bacteraemia and infective endocarditis’. Following his research, he moved back to Manchester to complete his urological training. Before starting as a consultant surgeon at the Manchester Royal Infirmary, Amar moved to Paris for a fellowship in robotic surgery and uro-oncology at the prestigious Henri Mondor Hospital, APHP, France.

He is currently the lead in urological cancer at the Manchester Royal Infirmary. He has set up the robotic programme for bladder cancer management at the MFT.

Professor Ananya Choudhury

The Christie NHS Foundation Trust

Professor Choudhury is Chair and Honorary Consultant in Clinical Oncology. She specialises in urology and sarcoma and has a strong interest in translational research. She is clinical lead for advanced radiotherapy including the MRLinac project and is co-Group Leader of The Translational Radiobiology Group within the Division of Cancer Sciences. She currently undertakes research which aims to optimise and personalise radiotherapy using new techniques or imaging technology to deliver high doses of radiotherapy while minimising side effects and predictive biomarkers to determine which patients benefit from different treatments.

Professor John Kelly

University College London

Professor John Kelly is a professor of Uro-oncology at University College London and Honorary Consultant Urologist at University College London Hospital. He was head of the Department of Urology at UCLH to 2020 and Director for robotic surgery at the Chitra Sethia Centre. He leads a genomics research group investigating epigenetic and genomic alterations in bladder cancer which can be exploited to predict outcomes and detect disease.

Mr Hugh Mostafid

Royal Surrey County Hospital

Mr Hugh Mostafid is a consultant urologist at the Royal Surrey County Hospital in Guildford and Honorary Senior Lecturer at the University of Surrey. His main research interests are the diagnosis and treatment of bladder cancer. He is also a member of the European Association of Urology Bladder Cancer guidelines panel.

Frequently Asked Questions

How do I view sessions?
The meeting will be streamed live through this site. A link will be made available approximately 10 minutes before the session is scheduled to start at 17.00 (UK Time) and you will be able to click through to the live stream at this time.
Do I need to download any software?
This meeting will be streamed using some of the latest technology to make it as simple as possible for you to watch. All you need is the latest version of your web browser installed We also recommend using a browser other than Internet Explorer – such as Firefox or Chrome - as older versions are no longer supported.
What do I need to view?
To view the live stream you will need an internet enabled device such as a PC, Laptop, Mac or Tablet. The bigger the screen the better so we don’t recommend using your mobile phone to view. You will also need headphones or speakers connected so you can hear the sound and perhaps a glass or mug of something (optional).
Can I use my iPad?
Absolutely, yes.
Where is it being held?
The live session is 'virtual’ and being hosted online – in fact, right here on this site.
What do I do if I have problems?
You won’t. But in the unlikely event that you do, you can contact technical support here. Try to be as descriptive as possible with the problem you are having so they can help you as efficiently as possible.